HHS Keeps 340B Orphan Drug Policy Despite Court Ruling
The U.S. Department of Health and Human Services on Wednesday said a recent court decision will not prevent it from requiring orphan drugs to sometimes be discounted under the controversial 340B...To view the full article, register now.
Already a subscriber? Click here to view full article